HIGHLIGHTS
- who: Chike Osude et al. from the Department of Biomedical Sciences, University of Illinois College of Medicine at Rockford have published the article: Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung Cancer, in the Journal: (JOURNAL)
- what: The low survival rate of NSCLC has led to many studies focusing on molecular targets with therapeutic potential for treatment of the disease . The authors have found that VEGF secretion was not increased in Erlotinib-resistant cells compared to parental cells. In this study, the main focus is to develop a better . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.